Clinical Trials Browser

Phase 2 × Abatacept × 1 year × Clear all

Graft vs Host Disease, Neoplasms

NCT07238712 2025-11-20

APTBCy

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT03680092 2025-10-02

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Phase 2 Completed

43 enrolled 10 charts

Other hematologic neoplasm

Graft vs Host Disease, Neoplasms, Hematologic Neoplasms

Clinical Trials

Abatacept as GVHD Prophylaxis Phase 2

APTBCy

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation